News/Events

Stay up to date with our latest news and events.

Proteos Recombinant Protein Expression and Purification

Recombinant Antigens: Selecting an Expression System

5/24/2021

There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens.  These variables include construct design, affinity tags, expression system, purification scheme, formulation, and characterization.  Here we will focus on selecting an appropriate expression system for recombinant antigen production.

Tags: antigen expression, bacterial, baculovirus, CHO, E coli, HEK, mammalian, recombinant protein production, Sf9, Tni

Proteos Celebrates Arbor Day

Celebrate Arbor Day

4/30/2021

In celebration of Arbor Day, let us all consider how we can contribute to conservation of our environment, for present and for future generations. 

Tags: Holiday

Recombinant Antigens: An Introduction

3/30/2021

There are many variables to consider when producing recombinant proteins, and more specifically recombinant antigens.  These variables include expression system, purification techniques, protein tags, formulation, and assessment.

Tags: antigen, drug discovery research, expression, purification, recombinant protein production

Proteos Recombinant Antibody Production IgG1

The Argument for Recombinant Antibody Production

2/23/2021

Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research.  Here we will focus on the benefits of producing mAbs recombinantly in mammalian cells.

Tags: Protein A purification, Recombinant antibody production, Transient Expression

Proteos Recombinant Antibody Production

Recombinant Antibody Production: The Argument Against Hybridomas

1/26/2021

Proteos is an industry leader in the production of high-quality recombinant antibodies for drug discovery research.  There are multiple methods for production of monoclonal antibodies, including hybridoma cell lines and recombinant protein technology.  The following information will discuss some of the limitations of hybridoma production.

Tags: IgG, mab, monoclonal antibody, Protein A purification, Recombinant antibody production, transient mammalian expression

Merry Christmas from Proteos

Happy Holidays from Proteos!

12/17/2020

Thank you to our valued customers for your business and support in 2020. We wish you a joyous holiday season and look forward to working with you in 2021.

Tags: Contract Research Organization, Holiday

Proteos Happy Thanksgiving

Happy Thanksgiving!

11/26/2020

Proteos would like to wish you, your family, and your friends a very Happy Thanksgiving!

Tags: Contract Research Organization, Holiday

Proteos Neuroscience Brain Research

Parkinson’s Disease Research Tools

10/15/2020

More than 6 million people worldwide are living with Parkinson’s Disease.  Proteos has proudly partnered with The Michael J. Fox Foundation to provide high-quality protein reagents in support of Parkinson’s disease research.

Tags: Alpha-synuclein, Michael J. Fox Foundation, recombinant protein production

Sunset on Lake Michigan shoreline

Let Proteos Help You Achieve Your 2020 Goals

9/24/2020

As we near this year’s final quarter, let Proteos help you achieve your drug discovery research goals for 2020.

Tags: Contract Research Organization, recombinant protein production

3-D image of protein structure

Affinity tag removal is an important consideration for project design

8/6/2020

Workflows for tackling challenging protein projects often utilize an affinity tag approach. In previous posts, we have discussed the purpose of utilizing affinity tags in recombinant protein production, the importance of selecting the proper tag for your specific protein target, and the importance of tag placement that can influence protein expression, purification, and functionality.  Our final post in this series will discuss removal of affinity tags.

Tags: Affinity tag purification, drug discovery research, expression, recombinant protein production

Customize This